Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 18, 2025. (Total: 235441Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Coronary Artery Disease and SLCO1B1[original query]
Common variants of four bilirubin metabolism genes and their association with serum bilirubin and coronary artery disease in Chinese Han population.
Pharmacogenetics and genomics 2009 Apr 19 (4): 310-8.
Lin Rong, Wang Ying, Wang Yi, Fu Wenqing, Zhang Dandan, Zheng Hongxiang, Yu Ting, Wang Ying, Shen Min, Lei Rong, Wu Hong, Sun Aijun, Zhang Ruifang, Wang Xiaofeng, Xiong Momiao, Huang Wei, Jin
Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia.
Molecular diagnosis & therapy 2013 Oct 17 (5): 299-309.
Shabana Mona F, Mishriki Amal A, Issac Marianne Samir M, Bakhoum Sameh W
SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.
European journal of clinical pharmacology 2017 Aug .
Liu Ju-E, Liu Xiao-Ying, Chen Sheng, Zhang Yan, Cai Li-Yun, Yang Min, Lai Wei-Hua, Ren Bin, Zhong Shi-Lo
Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease.
Archives of medical sciences. Atherosclerotic diseases 2017 2 e68-e75.
Shek Aleksandr B, Kurbanov Ravshanbek D, Abdullaeva Guzal J, Nagay Aleksandr V, Hoshimov Shavkat U, Nizamov Ulugbek I, Ziyaeva Adolat V, Alieva Rano
Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites.
Acta pharmacologica Sinica 2018 Jun .
Bai Xue, Zhang Bin, Wang Ping, Wang Guan-Lei, Li Jia-Li, Wen Ding-Sheng, Long Xing-Zhen, Sun Hong-Shuo, Liu Yi-Bin, Huang Min, Zhong Shi-Lo
Personalized rosuvastatin therapy in problem patients with partial statin intolerance.
Archives of medical sciences. Atherosclerotic diseases 2018 3 e83-e89.
Shek Aleksandr B, Kurbanov Ravshanbek D, Alieva Rano B, Abdullaeva Guzal J, Nagay Aleksandr V, Abdullaev Alisher A, Hoshimov Shavkat U, Nizamov Ulugbek
APOE gene ?4 allele (388C-526C) effects on serum lipids and risk of coronary artery disease in southern Chinese Hakka population.
Journal of clinical laboratory analysis 2021 7 35 (9): e23925.
Liu Qinghua, Wu Heming, Yu Zhikang, Huang Qingyan, Zhong Zhixio
SLCO1B1 and ABCB1 variants synergistically influence the atorvastatin treatment response in South Indian coronary artery disease patients.
Pharmacogenomics 2022 8 23 (12): 683-694.
Bharath Govindaswamy, Vishnuprabu Durairaj Pandian, Preethi Loganathan, Nagappan Arumugam Suriyam, Dhianeshwaran Isravanya Ramia Thiagaraja, Bhaskar Lakkakula Vks, Swaminathan Nagarajan, Munirajan Arasambattu Kann
CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease.
Frontiers in cardiovascular medicine 2023 1 9 1016126.
Dai Ruozhu, Zhao Xiaoyu, Zhuo Huilin, Wang Wei, Xu Yue, Hu Zixin, Zhang Tiexu, Zhao Jiangm
Drug-gene interactions in older patients with coronary artery disease.
BMC geriatrics 2024 10 24 (1): 881.
Shizhao Zhang, Chao Lv, Lisha Dong, Yangxun Wu, Tong Y
TOP